Publications: Justin Hicks

The United States faces a critical problem: an increasingly unskilled workforce. But what are we doing about it?

Rebuttal to Krugman's claims that innovation has lead to lower employment and lower wages.

Further evidence that debunks the myth that pharmaceutical companies aren't providing real value to the economy.

Robert J. Gordon’s latest no-growth forecast has received a lot of attention due to both the economic climate and its provocative nature.

R&D Tax Credits do increase innovative activity.

As the U.S. slides further behind in the international race to lure more tech and manufacturing investment, there needs to be a bold move by policy makers to ensure the United States moves back to the top from its current position at 27th in R&D tax incentives.

The Budget Control Act would be a hard hit to vital U.S. industries, competitiveness, and economic recovery.

Pharmaceutical proliferation leads to longer, wealthier lives.

A critique of the mainstream's take on the Fed's Bulletin on Family Finances '07-'10.

The neoclassical economics myopic focus on price blinds them to what is happening in the real economy and as such, leads policy makers to miss key things going on in the economy.